AzTrials
AzTrials

WellbeingNCT04476771

Cultivating Well-being in Subclinical Paranoia

A study testing Feliz-Mente (third generation psychotherapy) in people with Wellbeing, run by Universidad Complutense de Madrid at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and aims to build a more… Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Wellbeing
What is being tested?
Feliz-Mente (third generation psychotherapy)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSpain
Study dates
10 Oct 2017to 25 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Participants between 18 and 35 years old
  • At least two standard deviations above mean on the scales of distress, suspicion and /or interpersonal sensitivity in the SCL-90 questionnaire.

Who cannot join

  • Participants with borderline personality disorder
  • Participants with substance use disorders and /or
  • Participants with severe cognitive impairment.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Carmen Valiente

    Pozuelo de Alarcón, Madrid, 28223

Other trials in Spain

About this study

Official title: Cultivating Well-being Beyond Symptomatology in Subclinical Paranoia: A Randomized Controlled Trial

The intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and aims to build a more meaningful self-narrative in persons with subclinical paranoia. Feliz-Mente is a group intervention of 12 sessions in which participants are expected to perform exercises during and between sessions by the use of a mobile application to improve treatment adherence and daily practice. The design for the present study is a randomized controlled trial, which compares the post-intervention measures of the experimental group (group receiving the intervention and the daily use of a mobile application of the program) with the post-intervention measures of the control group (treatment as usual + waiting list).

Conditions
Wellbeing
Being tested
Feliz-Mente (third generation psychotherapy)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Feliz-Mente (third generation psychotherapy)Behavioural

    The intervention is delivered in a group format with a total of 12 sessions and a maximum of 10 patients per group. The protocol consists of specific exercises: 1: welcome and identification of emotions, 2: identification and amplification of positive emotions, 3: regulation of negative emotions, 4: gratitude, 5: forgiveness, 6: self-compassion, 7: personal strengths, 8: loving-kindness and positive interpersonal relationships, 9: values, 10: purpose of life, 11: resilience, 12: keeping the change and farewell party.

Study groups in NCT04476771
Study groupRoleWhat they receive
TAU + waiting listNo interventionFeliz-Mente (third generation psychotherapy):The intervention is delivered in a group format with a total of 12 sessions and a maximum of 10 patients per group. The protocol consists of specific exercises: 1: welcome and identification of emotions, 2: identification and amplification of positive emotions, 3: regulation of negative emotions, 4: gratitude, 5: forgiveness, 6: self-compassion, 7: personal strengths, 8: loving-kindness and positive interpersonal relationships, 9: values, 10: purpose of life, 11: resilience, 12: keeping the change and farewell party.
TAU + Feliz-Mente InterventionExperimentalFeliz-Mente (third generation psychotherapy):The intervention is delivered in a group format with a total of 12 sessions and a maximum of 10 patients per group. The protocol consists of specific exercises: 1: welcome and identification of emotions, 2: identification and amplification of positive emotions, 3: regulation of negative emotions, 4: gratitude, 5: forgiveness, 6: self-compassion, 7: personal strengths, 8: loving-kindness and positive interpersonal relationships, 9: values, 10: purpose of life, 11: resilience, 12: keeping the change and farewell party.
Receives: Behavioral: Feliz-Mente (third generation psychotherapy)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Well-being at 12 weeks, 3 months and 12 months

    Psychological Well-Being Scales (Ryff, 1995)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  2. Change from Well-being at 12 weeks, 3 months and 12 months

    Satisfaction with life Scale ( Diener et al. 1985)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

Secondary outcomes (6)
  1. Change from Well-beingDistress at 12 weeks, 3 months and 12 months

    Hospital Anxiety and Depression Scale (Bjelland et al. 2002)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  2. Change from self-esteem at 12 weeks, 3 months and 12 months

    Implicit self-esteem version: Go/No-Go Association Task (Nosek \& Banaji, 2001)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  3. Change from self-esteem at 12 weeks, 3 months and 12 months

    Rosenberg self-esteem scale (Rosenberg, 1965)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  4. Change from Attachment at 12 weeks, 3 months and 12 months

    Relationship Questionnaire (Bartholomew and Horowitz, 1991)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  5. Change from Paranoid ideation at 12 weeks, 3 months and 12 months

    Persecutory Ideation Questionnaire(McKay, Langdon and Coltheart, 2006)

    Measured: Change baseline, 12 weeks, 3 months and 12 months

  6. additional Outcome Measures Experience of trauma events

    Life Events Checklist for DSM-5 (Gray, 2004)

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2020
  2. Study start10 Oct 2017
  3. Primary completion25 Sep 2019
  4. Study completion25 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04476771
Sponsor's protocol ID
ComplutenseMadrid
Status last verified
Jul 2020
First submitted
10 Oct 2017
Last updated
20 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code

Questions about this trial

What is this clinical trial studying?

A study testing Feliz-Mente (third generation psychotherapy) in people with Wellbeing, run by Universidad Complutense de Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Well-being at 12 weeks, 3 months and 12 months (time frame: Change baseline, 12 weeks, 3 months and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in